Myriad Genetics Earns $2 Million Milestone From Schering-Plough | GenomeWeb

SALT LAKE CITY, Utah--Genomics company Myriad Genetics here recently announced that it has received a $2 million milestone payment from Schering-Plough as a result of new discoveries related to a gene involved in brain cancer. Further milestone and royalty payments may result from the research on the role of the MMAC1 gene in the pathogenesis of cancer in the future, Myriad added. The gene was discovered earlier in the year by Myriad and the University of Texas MD Anderson Cancer Center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.